CytoDyn (CYDY) Stock Statistics & Valuation Metrics

CytoDyn has a market cap or net worth of $328.46M. The enterprise value is $385.52M.

CytoDyn has 1,369,733,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

CytoDyn’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -45.06%.

The current PE Ratio of CytoDyn is ―. CytoDyn’s PEG ratio is -1.72.

In the last 12 months, CytoDyn had revenue of -5.92M and earned 3.75M in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was -17.98M and capital expenditures 0.00, giving a free cash flow of -17.98M billion.

CytoDyn pays an annual dividend of ―, resulting in a dividend yield of ―

CytoDyn upcoming earnings date is ―, ―.

CytoDyn as a current ratio of 0.25, with Debt / Equity ratio of -26.11%

In the past 12 months, CytoDyn has paid 0.00 in taxes.

CytoDyn EV to EBITDA ratio is 49.20, with an EV/FCF ratio of -48.38.

CytoDyn has $15.65M in cash and marketable securities with $27.23M in debt, giving a net cash position of -$11.58M billion.

Gross margin is 0.29%, with operating margin of -191.41%, and net profit margin of -63.30%.

The average price target for CytoDyn is ―, which is 11.43% higher than the current price. The consensus rating is ―